Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: AMPLITUDE THERAPEUTICS, INC.
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2024-08-20 to 2025-09-30
Current total value of award: $732812.94
Description: AMPLITUDE THERAPEUTICS-A SPLIT-FORMULATED TRANS-AMPLIFYING RNA ENCODED ANTI-NEURAMINIDASE MONOCLONAL ANTIBODY